Stockholders’ Equity and Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Shares Repurchased

A summary of the stock repurchase activity under the New Repurchase Program is as follows (in thousands, except per share amounts):

	Three Months Ended
	March 31, 2022
Aggregate purchase price	$	136,228
Shares repurchased	1,171
Average price paid per share	$	116.30

Schedule of Option Activity

The following table summarizes the option activity under our stock plans and related information (in thousands, except years and per share amounts):

	Number of Shares Underlying Outstanding Options	Weighted- Average Exercise Price per Share		Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value of Stock Options Outstanding
Balance—December 31, 2021	8,685	$	12.45	2.8	$	1,140,369
Options granted	—	—
Options exercised	(737)	10.09
Options canceled	(121)	18.11
Balance—March 31, 2022	7,827	$	12.58	2.6	$	989,294
Vested and exercisable—March 31, 2022	6,304	$	10.07	2.2	$	812,692

Schedule of Restricted Stock Units Activity

A summary of the RSU activity is presented below (in thousands, except years and per share amounts):

	Number of Shares	Weighted- Average Grant Date Fair Value Per Share		Weighted-Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value
Unvested balance—December 31, 2021	7,821	$	70.98	1.7	$	1,124,229
RSUs granted	758	107.79
RSUs vested	(742)	64.21
RSUs forfeited/canceled	(108)	70.81
Unvested balance—March 31, 2022	7,729	$	75.24	1.6	$	1,074,204

Schedule of Stock-Based Compensation Expense

The following table summarizes the stock-based compensation expense related to our equity awards (in thousands):

	Three Months Ended March 31,
	2022		2021
Cost of revenue	$	1,309	$	1,400
Research and development	27,576		21,982
Sales and marketing	13,109		10,085
General and administrative	8,285		4,086
Total stock-based compensation	$	50,279	$	37,553